33.04
price up icon1.60%   0.52
after-market 시간 외 거래: 33.04
loading
전일 마감가:
$32.52
열려 있는:
$32.39
하루 거래량:
79,124
Relative Volume:
0.50
시가총액:
$2.18B
수익:
$282.04M
순이익/손실:
$221.88M
주가수익비율:
9.8164
EPS:
3.3658
순현금흐름:
$-449.57M
1주 성능:
+1.04%
1개월 성능:
+4.59%
6개월 성능:
+15.97%
1년 성능:
+14.76%
1일 변동 폭
Value
$32.39
$33.24
1주일 범위
Value
$31.71
$33.91
52주 변동 폭
Value
$22.36
$37.78

갈라파고스 ADR Stock (GLPG) Company Profile

Name
명칭
Galapagos Nv Adr
Name
전화
-
Name
주소
-
Name
직원
704
Name
트위터
@GalapagosGlobal
Name
다음 수익 날짜
2025-07-23
Name
최신 SEC 제출 서류
Name
GLPG's Discussions on Twitter

GLPG을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GLPG
Galapagos Nv Adr
33.04 2.14B 282.04M 221.88M -449.57M 3.3658
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.15 118.84B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
812.27 81.61B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
422.50 53.69B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
822.94 49.49B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
176.00 37.34B 447.02M -1.18B -906.14M -6.1812

갈라파고스 ADR Stock (GLPG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-22 업그레이드 Leerink Partners Market Perform → Outperform
2025-08-05 다운그레이드 Deutsche Bank Hold → Sell
2025-02-14 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2024-11-20 다운그레이드 Kepler Hold → Reduce
2024-09-09 개시 Leerink Partners Market Perform
2024-08-02 다운그레이드 Raymond James Outperform → Mkt Perform
2024-03-28 다운그레이드 BofA Securities Neutral → Underperform
2024-03-07 재개 Morgan Stanley Equal-Weight
2023-08-24 다운그레이드 Citigroup Buy → Neutral
2023-05-05 업그레이드 Raymond James Mkt Perform → Outperform
2023-01-23 업그레이드 Jefferies Underperform → Hold
2022-11-07 다운그레이드 Raymond James Outperform → Mkt Perform
2022-09-09 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-01-27 업그레이드 Citigroup Neutral → Buy
2021-08-19 다운그레이드 Barclays Overweight → Equal Weight
2021-08-06 다운그레이드 Deutsche Bank Buy → Hold
2021-04-20 개시 Deutsche Bank Buy
2021-04-14 업그레이드 Barclays Equal Weight → Overweight
2021-02-23 업그레이드 BofA Securities Underperform → Neutral
2021-02-19 업그레이드 Raymond James Mkt Perform → Outperform
2021-02-11 다운그레이드 Citigroup Buy → Neutral
2021-01-19 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-11-19 개시 Maxim Group Buy
2020-10-21 다운그레이드 Goldman Neutral → Sell
2020-08-25 다운그레이드 Jefferies Buy → Hold
2020-08-24 다운그레이드 H.C. Wainwright Buy → Neutral
2020-08-19 다운그레이드 Barclays Overweight → Equal Weight
2020-08-19 업그레이드 Citigroup Neutral → Buy
2020-07-10 다운그레이드 Stifel Buy → Hold
2020-03-30 업그레이드 Jefferies Hold → Buy
2020-03-18 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2020-02-25 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2020-02-24 다운그레이드 BofA/Merrill Neutral → Underperform
2020-02-20 다운그레이드 RBC Capital Mkts Sector Perform → Underperform
2020-01-06 다운그레이드 JP Morgan Overweight → Neutral
2019-12-18 다운그레이드 Citigroup Buy → Neutral
2019-12-17 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2019-12-13 다운그레이드 Credit Suisse Outperform → Neutral
2019-12-02 개시 BofA/Merrill Neutral
2019-09-09 재개 Morgan Stanley Overweight
2019-07-31 업그레이드 UBS Neutral → Buy
2019-07-29 다운그레이드 Jefferies Buy → Hold
모두보기

갈라파고스 ADR 주식(GLPG)의 최신 뉴스

pulisher
Jan 06, 2026

Stock Market Today: Nasdaq Futures Pare Losses, Dow Drops After Scaling Record Highs— CoreWeave, Vistra, Microchip Technology In Focus (UPDATED) - Benzinga

Jan 06, 2026
pulisher
Jan 06, 2026

Stock Market Today: Nasdaq Futures Pare Losses, Dow Drops After Scaling Record Highs— CoreWeave, Vistra, Microchip Technology In Focus (UPDATED) - Benzinga

Jan 06, 2026
pulisher
Jan 06, 2026

AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga

Jan 06, 2026
pulisher
Dec 29, 2025

Galapagos NV (NASDAQ:GLPG) Given Average Rating of “Reduce” by Analysts - Defense World

Dec 29, 2025
pulisher
Dec 19, 2025

Galapagos stock holds steady as Raymond James maintains Market Perform rating By Investing.com - Investing.com South Africa

Dec 19, 2025
pulisher
Dec 19, 2025

Galapagos stock holds steady as Raymond James maintains Market Perform rating - Investing.com

Dec 19, 2025
pulisher
Nov 25, 2025

Bernstein initiates Market Perform rating on Galapagos stock with EUR27.90 target - Investing.com

Nov 25, 2025
pulisher
Nov 20, 2025

Galapagos NV (GLPG) Stock Price, Trades & News - GuruFocus

Nov 20, 2025
pulisher
Nov 16, 2025

Operating cash flow per share of Galapagos NV Sponsored ADR – NASDAQ:GLPG - TradingView

Nov 16, 2025
pulisher
Nov 16, 2025

Working capital per share of Galapagos NV Sponsored ADR – NASDAQ:GLPG - TradingView

Nov 16, 2025
pulisher
Nov 09, 2025

Galapagos NV (NASDAQ:GLPG) Receives Average Rating of “Reduce” from Analysts - Defense World

Nov 09, 2025
pulisher
Nov 07, 2025

EBIT per share of Galapagos NV Sponsored ADR – NASDAQ:GLPG - TradingView

Nov 07, 2025
pulisher
Nov 06, 2025

Earnings call transcript: Galapagos Q3 2025 sees earnings miss, stock steady By Investing.com - Investing.com Canada

Nov 06, 2025
pulisher
Nov 06, 2025

Earnings call transcript: Galapagos Q3 2025 sees earnings miss, stock steady - Investing.com

Nov 06, 2025
pulisher
Oct 22, 2025

Galapagos stock price target raised to $28 from $27 at RBC Capital - Investing.com

Oct 22, 2025
pulisher
Oct 22, 2025

Galapagos stock rating upgraded by Leerink Partners on cost-cutting moves - Investing.com

Oct 22, 2025
pulisher
Oct 21, 2025

PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Oct 21, 2025
pulisher
Oct 21, 2025

Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 21, 2025
pulisher
Oct 17, 2025

Galapagos Appoints Fred Blakeslee as General Counsel - The Globe and Mail

Oct 17, 2025
pulisher
Oct 14, 2025

Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN) - The Globe and Mail

Oct 14, 2025
pulisher
Oct 09, 2025

How Have Insiders Been Trading Winmark Corporation (WINA) Stock? - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why You Need Galapagos NV ADR (GLPG) On Your Watchlist - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Stock on Demand This Week: Hour Loop Inc (HOUR) - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

MasterCraft Boat Holdings Inc (MCFT): What the Financials Tell Us - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Buying Stock In Radiopharm Theranostics Ltd ADR (RADX) A Good Move Today? - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Major Brokerage Firms Issue Research Notes on Surgepays Inc (SURG) - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Vishay Precision Group Inc (VPG) Shares: Cheap or Risky? - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

Clene Inc (CLNN): What Technical Indicators Show - fostersleader.com

Oct 09, 2025
pulisher
Oct 09, 2025

SolarMax Technology Inc (SMXT): What Does Valuation Ratios Tell Us? - fostersleader.com

Oct 09, 2025
pulisher
Oct 02, 2025

Galapagos Updates on Cell Therapy Business Strategic Review - The Globe and Mail

Oct 02, 2025
pulisher
Aug 06, 2025

Galapagos (0JXZ) was downgraded to a Sell Rating at Deutsche Bank - The Globe and Mail

Aug 06, 2025
pulisher
Jul 25, 2025

Galapagos NV Reports Strong H1 2025 Results Amid Strategic Transformation - The Globe and Mail

Jul 25, 2025
pulisher
Jul 24, 2025

Raymond James reiterates Market Perform rating on Galapagos stock - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Raymond James reiterates Market Perform rating on Galapagos stock By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 23, 2025

Galapagos ADR earnings missed by $0.05, revenue topped estimates - Investing.com

Jul 23, 2025
pulisher
May 14, 2025

Galapagos stock holds as CEO change, spinoff plans halted By Investing.com - Investing.com India

May 14, 2025
pulisher
May 13, 2025

Galapagos stock holds as CEO change, spinoff plans halted - Investing.com

May 13, 2025
pulisher
Apr 24, 2025

Galapagos stock holds Market Perform rating at Raymond James - Investing.com

Apr 24, 2025
pulisher
Jan 21, 2025

Galapagos To Spin Off Innovative Medicines Business - Forbes

Jan 21, 2025
pulisher
Nov 20, 2024

Galapagos stock downgraded to Reduce on strategic concerns - Investing.com

Nov 20, 2024
pulisher
Nov 01, 2024

Earnings call: Galapagos reports solid Q3 progress, eyes IND studies - Investing.com

Nov 01, 2024
pulisher
Aug 26, 2024

Why This Rival To Gilead, Novartis Just Jumped 10% — And Why There Are Caveats - Investor's Business Daily

Aug 26, 2024
pulisher
Aug 02, 2024

Earnings call: Galapagos focuses on oncology and immunology in H1 2024 report - Investing.com

Aug 02, 2024
pulisher
Jun 17, 2024

Galapagos NV shares poised for outperformance, says TD Cowen - Investing.com

Jun 17, 2024
pulisher
May 30, 2024

Adaptimmune and Galapagos partner on cancer therapy - Investing.com

May 30, 2024
pulisher
May 06, 2024

Earnings call: Galapagos outlines strategic focus in Q1 2024 results - Investing.com

May 06, 2024
pulisher
Feb 08, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 08, 2024
pulisher
Dec 02, 2022

Billionaire hedge fund manager David Einhorn’s portfolio revealed - Daily Investor

Dec 02, 2022
pulisher
Apr 05, 2022

GLPG Stock Price and Chart — EURONEXT:GLPG - TradingView — Track All Markets

Apr 05, 2022
pulisher
Jan 27, 2022

Galapagos Surges On New CEO and Upgrade News - Investing.com

Jan 27, 2022
pulisher
Oct 16, 2020

The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs - Yahoo Finance

Oct 16, 2020

갈라파고스 ADR (GLPG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
자본화:     |  볼륨(24시간):